Transient expression of antinuclear RNP-A antibodies in patients with acute COVID-19 infection.

Zhou, Shuxia; Kaul, Ravi; Lynch, Kara L; Wu, Alan H B; Walker, Roger P

Zhou, Shuxia; Kaul, Ravi; Lynch, Kara L; Wu, Alan H B; Walker, Roger P.

Afiliação

Zhou S; Bio-Rad Laboratories, Hercules, CA, USA.
Kaul R; Bio-Rad Laboratories, Hercules, CA, USA.
Lynch KL; Department of Laboratory Medicine, University of California, San Francisco, USA.
Wu AHB; Department of Laboratory Medicine, University of California, San Francisco, USA.
Walker RP; Bio-Rad Laboratories, Hercules, CA, USA.

J Transl Autoimmun ; 5: 100175, 2022.

Article em En | MEDLINE | ID: mdl-36447819

Palavras-chave

ACE2, angiotensin-converting enzyme 2; ANA, antinuclear antibody; Antinuclear antibody; COVID-19; COVID-19, coronavirus disease 2019; ICU, intensive care unit; IFA, Immunofluorescence assay; MCTD, mixed connective tissue disease; N, SARS-CoV-2 nucleocapsid protein; Nab, neutralizing antibody; Neutralizing antibody; Nucleocapsid protein; PSO, post symptom onset; RNP-A; RNP-A, ribonucleoprotein A; SARS-CoV-2; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; sVNT, surrogate viral neutralization test

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: J Transl Autoimmun Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google